These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 16524673

  • 21. Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.
    Yuzawa S, Opatowsky Y, Zhang Z, Mandiyan V, Lax I, Schlessinger J.
    Cell; 2007 Jul 27; 130(2):323-34. PubMed ID: 17662946
    [Abstract] [Full Text] [Related]

  • 22. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
    Horn S, Bergholz U, Jücker M, McCubrey JA, Trümper L, Stocking C, Bäsecke J.
    Oncogene; 2008 Jul 03; 27(29):4096-106. PubMed ID: 18317450
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.
    Choudhary C, Olsen JV, Brandts C, Cox J, Reddy PN, Böhmer FD, Gerke V, Schmidt-Arras DE, Berdel WE, Müller-Tidow C, Mann M, Serve H.
    Mol Cell; 2009 Oct 23; 36(2):326-39. PubMed ID: 19854140
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Origin and molecular evolution of receptor tyrosine kinases with immunoglobulin-like domains.
    Grassot J, Gouy M, Perrière G, Mouchiroud G.
    Mol Biol Evol; 2006 Jun 23; 23(6):1232-41. PubMed ID: 16551648
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Novel protein kinases and molecular mechanisms of autoinhibition.
    Cheetham GM.
    Curr Opin Struct Biol; 2004 Dec 23; 14(6):700-5. PubMed ID: 15582394
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Receptor tyrosine kinases in normal and malignant haematopoiesis.
    Reilly JT.
    Blood Rev; 2003 Dec 23; 17(4):241-8. PubMed ID: 14556779
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Autoinhibition of the Ron receptor tyrosine kinase by the juxtamembrane domain.
    Wang X, Yennawar N, Hankey PA.
    Cell Commun Signal; 2014 Apr 16; 12():28. PubMed ID: 24739671
    [Abstract] [Full Text] [Related]

  • 36. Autoinhibitory mechanisms in receptor tyrosine kinases.
    Hubbard SR.
    Front Biosci; 2002 Feb 01; 7():d330-40. PubMed ID: 11815286
    [Abstract] [Full Text] [Related]

  • 37. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases.
    Ostman A, Böhmer FD.
    Trends Cell Biol; 2001 Jun 01; 11(6):258-66. PubMed ID: 11356362
    [Abstract] [Full Text] [Related]

  • 38. Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics.
    Li E, Hristova K.
    Cell Adh Migr; 2010 Jun 01; 4(2):249-54. PubMed ID: 20168077
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.
    Li E, Hristova K.
    Biochemistry; 2006 May 23; 45(20):6241-51. PubMed ID: 16700535
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.